Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID), 71068 [2021-26954]
Download as PDF
<![CDATA[
jspears on DSK121TN23PROD with NOTICES1
71068
Federal Register / Vol. 86, No. 237 / Tuesday, December 14, 2021 / Notices
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: The docket
will be opened to receive written
comments on December 14, 2021.
Written comments must be received on
or before January 12, 2022.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the January 12, 2022
ACIP meeting must submit a request at
https://www.cdc.gov/vaccines/acip/
meetings/ no later than 11:59 p.m., EST,
January 7, 2022, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by January 10, 2022. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
18:24 Dec 13, 2021
Jkt 256001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–26956 Filed 12–13–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC,
DDID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Deputy Director for Infectious Diseases
(BSC, DDID). This virtual meeting is
open to the public via Zoom, limited
only by the space available, which is
500 seats. Pre-registration is required by
accessing the link below in the
addresses section.
DATES: The meeting will be held on
January 19–20, 2022, from 1:00 p.m. to
5:30 p.m., EST.
ADDRESSES: Zoom virtual meeting. Preregistration is required by accessing the
link at https://cdc.zoomgov.com/
webinar/register/WN_
vXuOtDbNQIycPMScOPKvKQ.
Instructions to access the meeting will
be provided following registration.
FOR FURTHER INFORMATION CONTACT:
Hilary Eiring, MPH, Designated Federal
Officer, CDC, 1600 Clifton Road NE,
Mailstop H24–12, Atlanta, Georgia
30329–4027, Telephone: (770) 488–
3901; Email: HEiring@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board provides advice
and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the Director
and the Deputy Director for Infectious
Diseases (DDID), CDC; and the Directors
of the National Center for Emerging and
Zoonotic Infectious Diseases, the
National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, and the
National Center for Immunization and
Respiratory Diseases, CDC, in the
following areas: Strategies, goals, and
priorities for programs and research
within the national centers and monitor
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
the overall strategic direction and focus
of DDID and the national centers.
Matters To Be Considered: The agenda
will include updates and discussions on
recent outbreaks; updates and
discussions on CDC’s Center for
Forecasting and Outbreak Analytics,
advanced molecular detection program,
Data Modernization Initiative, and
CORE Health Equity Science and
Intervention Strategy; and other updates
and reports, including a brief report
back from the Board’s Food Safety
Modernization Act Surveillance
Working Group. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–26954 Filed 12–13–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463.
Name of Committee: Safety and
Occupational Health Study Section (SOHSS),
National Institute for Occupational Safety
and Health (NIOSH).
Dates: February 16–17, 2022.
Time: 11:00 a.m.—5:00 p.m., EST.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the study
section to consider safety and occupational
health-related grant applications.
E:\FR\FM\14DEN1.SGM
14DEN1
]]>Agencies
[Federal Register Volume 86, Number 237 (Tuesday, December 14, 2021)]
[Notices]
[Page 71068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26954]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Deputy Director for Infectious
Diseases (BSC, DDID)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
Deputy Director for Infectious Diseases (BSC, DDID). This virtual
meeting is open to the public via Zoom, limited only by the space
available, which is 500 seats. Pre-registration is required by
accessing the link below in the addresses section.
DATES: The meeting will be held on January 19-20, 2022, from 1:00 p.m.
to 5:30 p.m., EST.
ADDRESSES: Zoom virtual meeting. Pre-registration is required by
accessing the link at https://cdc.zoomgov.com/webinar/register/WN_vXuOtDbNQIycPMScOPKvKQ. Instructions to access the meeting will be
provided following registration.
FOR FURTHER INFORMATION CONTACT: Hilary Eiring, MPH, Designated Federal
Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia
30329-4027, Telephone: (770) 488-3901; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board provides advice and guidance to the Secretary,
Department of Health and Human Services; the Director, CDC; the
Director and the Deputy Director for Infectious Diseases (DDID), CDC;
and the Directors of the National Center for Emerging and Zoonotic
Infectious Diseases, the National Center for HIV, Viral Hepatitis, STD,
and TB Prevention, and the National Center for Immunization and
Respiratory Diseases, CDC, in the following areas: Strategies, goals,
and priorities for programs and research within the national centers
and monitor the overall strategic direction and focus of DDID and the
national centers.
Matters To Be Considered: The agenda will include updates and
discussions on recent outbreaks; updates and discussions on CDC's
Center for Forecasting and Outbreak Analytics, advanced molecular
detection program, Data Modernization Initiative, and CORE Health
Equity Science and Intervention Strategy; and other updates and
reports, including a brief report back from the Board's Food Safety
Modernization Act Surveillance Working Group. Agenda items are subject
to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-26954 Filed 12-13-21; 8:45 am]
BILLING CODE 4163-18-P
